Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lucy Safi

Cardiovascular Disease New York, NY Doctor of Osteopathy

NPI 1164659603 CMS profile 188504

1190 5Th Ave, New York, NY 10029

Open in the dashboard

General payments

$147,884

500 records reported · program years 2019–2025

Research payments

$92

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lucy Safi of New York, NY is reported in the CMS Open Payments database as having received $147,884 across 500 general payments and $92 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,418 82
2024 General $36,117 132
2024 Research $92 1
2023 General $37,695 111
2022 General $27,790 95
2021 General $23,492 39
2020 General $1,084 19
2019 General $2,289 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lucy Safi
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Lucy Safi were reported at $19,418. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Lucy Safi Cardiovascular Disease median Middle half National median
2019 $2,289 $450 $127–$1,392 $163
2020 $1,084 $242 $77–$751 $114
2021 $23,492 $335 $101–$1,037 $132
2022 $27,790 $395 $121–$1,211 $149
2023 $37,695 $443 $136–$1,283 $160
2024 $36,117 $450 $136–$1,323 $164
2025 $19,418 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $71,662 219 payments
  2. Medtronic, Inc. $57,930 150 payments
  3. Edwards Lifesciences Corporation $7,417 65 payments
  4. Siemens Medical Solutions USA, Inc. $5,719 8 payments
  5. Abiomed $852 12 payments
  6. Shockwave Medical, Inc $847 8 payments
  7. Philips Electronics North America Corporation $831 2 payments
  8. Boston Scientific Corporation $418 7 payments
  9. Medtronic Vascular, Inc. $372 6 payments
  10. CVRx, Inc. $349 2 payments
  11. Other $1,486 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,385 19 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $37,063 13 payments
  3. Food and Beverage $27,153 363 payments
  4. Travel and Lodging $21,033 100 payments
  5. Consulting Fee $12,250 5 payments
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $51,875 111 payments
  2. MITRACLIP Structural Heart $21,661 40 payments
  3. MitraClip System $19,035 23 payments
  4. TRICLIP $9,243 21 payments
  5. MITRACLIP Vascular $6,186 9 payments
  6. ACUSON Origin Diagnostic Ultrasound System $4,954 5 payments
  7. CoreValve Evolut $3,172 4 payments
  8. EVOQUE $2,264 11 payments
  9. SAPIEN 3 Ultra RESILIA $1,827 21 payments
  10. MITRACLIP Vascular $1,506 30 payments
  11. Other $15,747 177 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $92 1 payment

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$100,359

Medicare's payments for the services billed

Medicare patients

945

Average age 77

Services billed

1,640

438 women, 507 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 69%
Heart failure 62%
Arthritis 53%
Atrial fibrillation 49%
Diabetes 48%
Chronic kidney disease 44%
Cancer 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

501 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record